Roman A. Gryaznev
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Roman A. Gryaznev has a total of 9 co-authors. Here are the top co-authors by number of shared publications:
- Elena A. Malykhina
Federal Center of Brain Research and Neurotechnologies
2 shared publications - Elena Anatolyevna Katunina
Federal Center for Brain and Neurotechnologies of the Federal Medical-Biological Agency of Russia
2 shared publications - Ivan Sergeevich Gumin
Federal Center of Brain Research and Neurotechnologies
2 shared publications - Mikhail Borisovich Dolgushin
Federal Center of Brain Research and Neurotechnologies
2 shared publications - Natalia Nikolaevna Shipilova
Federal Center of Brain Research and Neurotechnologies
2 shared publications - Vijay Mais-Ogly Dzhafarov
Federal Center of Brain Research and Neurotechnologies
2 shared publications
Latest Publications
- Open Access
- 28 March 2026
- Published by ECO-Vector LLC (Publications) in Journal of Clinical Practice
- Vol. 17 (1) , 119-130
FUS-thalamotomy in the correction of tremors in fragile X-associated tremors/ataxia syndrome (FXTAS)
BACKGROUND: Tremor/ataxia syndrome associated with a brittle X chromosome is a rare neurodegenerative disease. CLINICAL CASE DESCRIPTION: The article presents the clinical case of a 62 years old patient, suffering from hand tremors from the age of 5–7 with gradual onset of tremors in the head (with vocal jitter) and in the chin with further development of ataxia and mild dysarthria. After DNA-testing, the patient was diagnosed with increased levels of cytosine-guanine-guanine (CGG) trinucleotide repeats in the FMR1 gene of the Х-chromosome. Due to the absence of effect from conservative therapy and the unremitting progression of the severity of tremors, reaching the incapacitating levels, the patient underwent the stereotaxic destruction of the ventrolateral nucleus of the thalamus with focused ultrasound guided by magnetic resonance imaging (MRI) on the left side. During the process of the surgical intervention, a total of six ultrasonic exposures were delivered with achieving, based on the results of MR-thermometry, the average temperature levels of 57–60°С. The duration of treatment was 120 minutes. Right after the surgical intervention, significant clinical improvement was achieved: by 48% according to the Clinical Rating Scale for Tremor (CRST), by 80% according to the hemi-CRST (modified version of CRST for the evaluation of tremors on a single side of the body); the improvement of everyday activity according to the CRST (part С) was 87%. Thalamotomy with focused ultrasound (FUS-thalamotomy) did not cause any significant effect in this patient in terms of the aggravation of ataxia, of coordination or speech disorders. CONCLUSION: The presented clinical case demonstrates the complexity of setting the FXTAS diagnosis, as well as the necessity for the differential diagnostics of fragile Х-associated tremors and ataxia syndrome with a vast spectrum of hereditary diseases, manifesting with extrapyramidal symptoms and cognitive dysfunction. Due to the low efficiency of symptomatic medication therapy in FXTAS patients, the methods of functional neurosurgery should be considered, among which, recently more attention is gained by the MRgFUS method as the least invasive and as the safe one in the elderly individuals. As of today, the experience of performing the MRgFUS in patients with FXTAS syndrome is insignificant and contains the descriptions of single cases in foreign literature. This clinical case, the first experience of performing FUS-MRI in a patient with FXTAS syndrome in Russia, has demonstrated the potential of this approach, but further studies involving a larger number of patients and a longer observation period are certainly needed.
- 28 March 2026
- Published by ECO-Vector LLC (Publications) in Journal of Clinical Practice
- Vol. 17 (1) , 119-130
Open AccessFUS-thalamotomy in the correction of tremors in fragile X-associated tremors/ataxia syndrome (FXTAS)
BACKGROUND: Tremor/ataxia syndrome associated with a brittle X chromosome is a rare neurodegenerative disease. CLINICAL CASE DESCRIPTION: The article presents the clinical case of a 62 years old patient, suffering from hand tremors from the age of 5–7 with gradual onset of tremors in the head (with vocal jitter) and in the chin with further development of ataxia and mild dysarthria. After DNA-testing, the patient was diagnosed with increased levels of cytosine-guanine-guanine (CGG) trinucleotide repeats in the FMR1 gene of the Х-chromosome. Due to the absence of effect from conservative therapy and the unremitting progression of the severity of tremors, reaching the incapacitating levels, the patient underwent the stereotaxic destruction of the ventrolateral nucleus of the thalamus with focused ultrasound guided by magnetic resonance imaging (MRI) on the left side. During the process of the surgical intervention, a total of six ultrasonic exposures were delivered with achieving, based on the results of MR-thermometry, the average temperature levels of 57–60°С. The duration of treatment was 120 minutes. Right after the surgical intervention, significant clinical improvement was achieved: by 48% according to the Clinical Rating Scale for Tremor (CRST), by 80% according to the hemi-CRST (modified version of CRST for the evaluation of tremors on a single side of the body); the improvement of everyday activity according to the CRST (part С) was 87%. Thalamotomy with focused ultrasound (FUS-thalamotomy) did not cause any significant effect in this patient in terms of the aggravation of ataxia, of coordination or speech disorders. CONCLUSION: The presented clinical case demonstrates the complexity of setting the FXTAS diagnosis, as well as the necessity for the differential diagnostics of fragile Х-associated tremors and ataxia syndrome with a vast spectrum of hereditary diseases, manifesting with extrapyramidal symptoms and cognitive dysfunction. Due to the low efficiency of symptomatic medication therapy in FXTAS patients, the methods of functional neurosurgery should be considered, among which, recently more attention is gained by the MRgFUS method as the least invasive and as the safe one in the elderly individuals. As of today, the experience of performing the MRgFUS in patients with FXTAS syndrome is insignificant and contains the descriptions of single cases in foreign literature. This clinical case, the first experience of performing FUS-MRI in a patient with FXTAS syndrome in Russia, has demonstrated the potential of this approach, but further studies involving a larger number of patients and a longer observation period are certainly needed.
- 6 October 2025
- Published by Media Sphere Publishing Group in S.S. Korsakov Journal of Neurology and Psychiatry
- Vol. 125 (9) , 79-89
A prospective study of MRI-guided focused ultrasound thalamotomy in essential tremor
Objective. To study the effect of magnetic resonance imaging-guided focused ultrasound (MR-FUS) on the motor and non-motor symptoms of essential tremor (ET) (cognitive functions, anxiety, depression, apathy, sleep disorders), as well as to establish association between adverse events (AEs) and the technical parameters of the surgery, postablation neuroimaging changes in the brain matter, and clinical and demographic factors. Material and methods. Twenty-two patients with disabling drug-resistant ET were prospectively evaluated prior to unilateral ventral intermediate nucleus (Vim) FUS thalamotomy, and at 24 hours, 3, 6, and 12 months postoperatively. The change of tremor was assessed using the Clinical Rating Scale for Tremor (CRST). Non-motor symptoms were assessed using the Montreal Cognitive Assessment (MoCA), the Beck Depression Inventory (BDI) and Beck Anxiety Inventory (BAI), the Apathy Scale, and the Epworth Sleepiness Scale. The Tinetti test was used to assess balance and gait. The quality of life for patients with ET was assessed using the Quality of Life in Essential Tremor Questionnaire (QUEST). MRI with a magnetic field strength of 3.0 T was performed immediately after surgery, as well as at 24 hours, 3, 6, and 12 months post-surgery. Results. MR-FUS led to a significant reduction in tremor in the extremities of the contralateral thalamotomy site; the mean total CRST and hemi-CRST scores decreased by 78% and 80% (p0.05). Mild adverse events occurred in 45% of patients immediately after surgery, and most of the AEs regressed by Month 3 of follow-up. The lesion volume and postoperative edema were significantly correlated with a decrease in the total CRST score at 6 and 12 months postoperatively (r=–1, p=0.01). The results of the correlation analysis showed that patients with AEs after FUS-thalamotomy had larger foci of necrosis and postoperative edema, and also had a significantly shorter duration of surgery (p=0.042). However, the number of sonications (both verification and therapeutic), the power of ultrasound waves, and the maximum exposure temperatures in the patients of the compared groups did not differ significantly. Conclusion. The results of an open prospective study confirmed the effectiveness of unilateral FUS thalamotomy of the Vim nucleus of the thalamus for the treatment of ET. There was no significant effect on the non-motor manifestations of ET. All reported AEs were mild and transient. The risk of AEs was determined by the volume of the lesion and postoperative edema, as well as the duration of surgery.
- 6 October 2025
- Published by Media Sphere Publishing Group in S.S. Korsakov Journal of Neurology and Psychiatry
- Vol. 125 (9) , 79-89
A prospective study of MRI-guided focused ultrasound thalamotomy in essential tremor
Objective. To study the effect of magnetic resonance imaging-guided focused ultrasound (MR-FUS) on the motor and non-motor symptoms of essential tremor (ET) (cognitive functions, anxiety, depression, apathy, sleep disorders), as well as to establish association between adverse events (AEs) and the technical parameters of the surgery, postablation neuroimaging changes in the brain matter, and clinical and demographic factors. Material and methods. Twenty-two patients with disabling drug-resistant ET were prospectively evaluated prior to unilateral ventral intermediate nucleus (Vim) FUS thalamotomy, and at 24 hours, 3, 6, and 12 months postoperatively. The change of tremor was assessed using the Clinical Rating Scale for Tremor (CRST). Non-motor symptoms were assessed using the Montreal Cognitive Assessment (MoCA), the Beck Depression Inventory (BDI) and Beck Anxiety Inventory (BAI), the Apathy Scale, and the Epworth Sleepiness Scale. The Tinetti test was used to assess balance and gait. The quality of life for patients with ET was assessed using the Quality of Life in Essential Tremor Questionnaire (QUEST). MRI with a magnetic field strength of 3.0 T was performed immediately after surgery, as well as at 24 hours, 3, 6, and 12 months post-surgery. Results. MR-FUS led to a significant reduction in tremor in the extremities of the contralateral thalamotomy site; the mean total CRST and hemi-CRST scores decreased by 78% and 80% (p0.05). Mild adverse events occurred in 45% of patients immediately after surgery, and most of the AEs regressed by Month 3 of follow-up. The lesion volume and postoperative edema were significantly correlated with a decrease in the total CRST score at 6 and 12 months postoperatively (r=–1, p=0.01). The results of the correlation analysis showed that patients with AEs after FUS-thalamotomy had larger foci of necrosis and postoperative edema, and also had a significantly shorter duration of surgery (p=0.042). However, the number of sonications (both verification and therapeutic), the power of ultrasound waves, and the maximum exposure temperatures in the patients of the compared groups did not differ significantly. Conclusion. The results of an open prospective study confirmed the effectiveness of unilateral FUS thalamotomy of the Vim nucleus of the thalamus for the treatment of ET. There was no significant effect on the non-motor manifestations of ET. All reported AEs were mild and transient. The risk of AEs was determined by the volume of the lesion and postoperative edema, as well as the duration of surgery.